Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment

Launched by MCLEAN HOSPITAL · Dec 1, 2014

Keywords

ClinConnect Summary

This clinical trial is studying how effective the McLean Anxiety Mastery Program is in treating various anxiety disorders, such as Social Anxiety Disorder, Specific Phobia, Separation Anxiety Disorder, Panic Disorder, Agoraphobia, and Obsessive-Compulsive Disorder. Researchers will collect information from patients about their experiences before, during, and after treatment to see if those receiving treatment improve more than those who are on a waitlist. They will also check if the improvements last for three months after treatment ends.

To be eligible for this study, participants must be between 6 and 19 years old and have at least one of the anxiety disorders mentioned. Interested patients and their caregivers can apply online to start the process. It’s important to note that individuals with certain severe issues, like recent substance abuse or active symptoms of psychosis, cannot participate. All sessions will be conducted in English, but translation services are available for parents who may need them. Participants can expect to share their thoughts and feelings about their anxiety throughout the treatment process, helping researchers understand how well the program works.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All youth who are eligible to participate in the McLean Anxiety Mastery Program will be invited to participate in the research study.
• * Eligibility criteria for the McLean Anxiety Mastery Program include:
• • children and adolescents who are between the ages of 6 and 19 and
• * who present with at least one of the following disorders:
• • Separation Anxiety Disorder,
• • Social Anxiety Disorder,
• • Panic Disorder,
• • Agoraphobia,
• • Specific Phobia(s), and
• • OCD.
• • Interested and eligible patients and their caregivers should complete and submit an application (https://www.mcleanhospital.org/sites/default/files/2021-07/MAMP-Application-07032021_0.pdf) to begin the phone screen process.
• Exclusion Criteria:
• • Patients ineligible for the treatment program, and therefore the study, include those who have engaged in substance abuse during the six weeks prior to the first evaluation (i.e., waitlist or admission) the phone screening,
• • those who report that they are unwilling to refrain from self-injurious behaviors during the waitlist and treatment periods,
• • those who are experiencing active symptoms of psychosis,
• • those who exhibit severe behavioral disinhibition or aggression, and
• • those who express an intent and/or plan to commit suicide or homicide at the time of their first evaluation the initial phone screening.
• • Patients must be fluent in English to participate in the program because all off-grounds exposure groups will be conducted in English (whenever possible, however, translation services will be provided for patients whose parents are not fluent in English).